Bio-Rad Laboratories Inc. ("Bio-Rad") and 10x Genomics, Inc. ("10x Genomics") have reportedly settled
more than 20 separate patent disputes across a multitude of venues and jurisdictions. A copy of the settlement and patent cross-license agreement, which was filed with the SEC, can be accessed here.
Bio-Rad is based in Hercules,
California and develops and manufactures products for the life sciences research and clinical diagnostic markets.
10x Genomics is based in Pleasanton, California
and designs and manufactures gene sequencing technology used in scientific research. At least some of the founders of 10x Genomics were former employees of Bio-Rad.
Very generally, the patent disputes related to technology for the isolation of individual cells for genetic analysis on microscopic droplets.
As of June 1, 2026, the Trademarks Opposition Board (TMOB) requires all confidential evidence and documentation in proceedings under sections 11.13, 38, or 45 of the Trademarks Act (the “Act”) to be…
The sneaker company, 1587 Sneakers, is reportedly suing Kansas City Chiefs players, Patrick Mahomes and Travis Kelce, along with their restaurant partners, for trademark infringement.1587 Sneakers…
As reported by Bloomberg Law News, PEI Licensing (“PEI”), the owner of the Penguin apparel brand, has sued Pudgy Penguins NFT (“Pudgy Penguins”) for trademark infringement.Pudgy Penguins started as a…
Nike is reportedly attempting to revive its classic “Total 90” soccer cleat line, but has encountered an unexpected setback. Total90, LLC has reportedly asserted that Nike is infringing its…
As reported by Bloomberg, attempts to register marks covering the phrases “All Rise” and “Here Comes the Judge” were rejected by the U.S. Court of Appeals for the Federal Circuit. In…
The Federal Court of Appeal’s recent decision in Promotion in Motion, Inc. (PIM Brands, Inc.) v. Hershey Chocolate & Confectionery LLC offers fresh guidance on how courts evaluate survey evidence…
